Lack of Benefit of Fluvoxamine for COVID-19. Bhimraj A, Gallagher JC. JAMA 2023 Jan 12. doi: 10.1001/jama.2022.23954.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bhimraj A, Gallagher JC. Lack of Benefit of Fluvoxamine for COVID-19. JAMA 2023 Jan 12. doi: 10.1001/jama.2022.23954.
PMID: 36633871